Cantor Fitzgerald Resumes Humanigen (HGEN) at Neutral, 'we remain on the sidelines until earnings visibility improves'
Tweet Send to a Friend
Cantor Fitzgerald analyst Louise Chen resumes coverage on Humanigen (NASDAQ: HGEN) with a Neutral rating and a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
